{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T14:00:32Z","timestamp":1781272832393,"version":"3.54.1"},"reference-count":19,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,2,8]]},"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:p>A 68-year-old woman presented with profound vision loss of 2-month duration in the right eye and 1-week duration in her left eye. This occurred in the context of craniopharyngioma that was twice resected and irradiated (54\u2009Gy in 30 fractions) 9 months before her presentation. Ophthalmological examination revealed hand motion vision in the right eye and light perception vision in the left eye with poorly reactive pupils and bilateral optic disc pallor. A non-contrast MRI of the brain and sella showed significant reduction of the sellar mass. A repeat MRI of the brain and orbits with gadolinium showed pre-chiasmatic enhancement of both optic nerves. The diagnosis of radiation-induced optic neuropathy was made. Despite treatment with high-dose intravenous corticosteroids, 19 sessions of hyperbaric oxygen therapy, and 3 doses of intravenous bevacizumab, her vision worsened to no light perception in both eyes.<\/jats:p>","DOI":"10.1136\/bcr-2019-233706","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T04:15:23Z","timestamp":1582776923000},"page":"e233706","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Catastrophic vision loss from radiation-induced optic neuropathy"],"prefix":"10.1136","volume":"13","author":[{"given":"Sultan","family":"Aldrees","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4911-9152","authenticated-orcid":false,"given":"Jonathan A","family":"Micieli","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,2,26]]},"reference":[{"key":"2025082803512801000_13.2.e233706.1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00041327-200409000-00003","article-title":"Lack of radiation optic neuropathy in 72 patients treated for pituitary adenoma","volume":"24","author":"van den Bergh","year":"2004","journal-title":"J Neuroophthalmol"},{"key":"2025082803512801000_13.2.e233706.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2007.09.004"},{"key":"2025082803512801000_13.2.e233706.3","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0360-3016(94)90346-8","article-title":"Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of Time-dose factors","volume":"30","author":"Parsons","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025082803512801000_13.2.e233706.4","first-page":"207","article-title":"Radiation-Induced damage in the central nervous system: an interpretation of target cell responses","volume":"7","author":"van der Kogel","year":"1986","journal-title":"Br J Cancer Suppl"},{"key":"2025082803512801000_13.2.e233706.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(90)32537-X"},{"key":"2025082803512801000_13.2.e233706.6","doi-asserted-by":"publisher","DOI":"10.1016\/0167-8140(94)90005-1"},{"key":"2025082803512801000_13.2.e233706.7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/WNO.0000000000000670","article-title":"Radiation-Induced optic neuropathy: clinical and imaging profile of twelve patients","volume":"39","author":"Archer","year":"2019","journal-title":"J Neuroophthalmol"},{"key":"2025082803512801000_13.2.e233706.8","doi-asserted-by":"publisher","DOI":"10.1530\/acta.0.1220559"},{"key":"2025082803512801000_13.2.e233706.9","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/84.1.85"},{"key":"2025082803512801000_13.2.e233706.10","doi-asserted-by":"publisher","DOI":"10.1148\/120.1.167"},{"key":"2025082803512801000_13.2.e233706.11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0360-3016(77)90007-4","article-title":"Relationship of time dose factors to tumor control and complications in the treatment of Cushing's disease by irradiation","volume":"2","author":"Aristizabal","year":"1977","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025082803512801000_13.2.e233706.12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF02743457","article-title":"Radiation-Induced bilateral optic neuropathy in cancer of the nasopharynx. Case failure analysis and a review of the literature","volume":"175","author":"Wijers","year":"1999","journal-title":"Strahlenther Onkol"},{"key":"2025082803512801000_13.2.e233706.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2012.05.034"},{"key":"2025082803512801000_13.2.e233706.14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0002-9394(73)90563-1","article-title":"Delayed radiation necrosis of the optic nerve","volume":"76","author":"Ross","year":"1973","journal-title":"Am J Ophthalmol"},{"key":"2025082803512801000_13.2.e233706.15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1442-9071.2004.00809.x","article-title":"Radiation-Induced optic neuropathy: still no treatment","volume":"32","author":"Miller","year":"2004","journal-title":"Clin Exp Ophthalmol"},{"key":"2025082803512801000_13.2.e233706.16","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02161"},{"key":"2025082803512801000_13.2.e233706.17","doi-asserted-by":"crossref","DOI":"10.1007\/s11940-014-0325-2","article-title":"In search of a treatment for radiation-induced optic neuropathy","volume":"17","author":"Indaram","year":"2015","journal-title":"Curr Treat Options Neurol"},{"key":"2025082803512801000_13.2.e233706.18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/WNO.0b013e3182607381","article-title":"Novel treatment for radiation optic neuropathy with intravenous bevacizumab","volume":"32","author":"Farooq","year":"2012","journal-title":"J Neuroophthalmol"},{"key":"2025082803512801000_13.2.e233706.19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ijrobp.2010.11.075","article-title":"Antivascular endothelial growth factor bevacizumab for radiation optic neuropathy: secondary to plaque radiotherapy","volume":"82","author":"Finger","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-233706","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:51:33Z","timestamp":1756378293000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-233706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,26]]},"published-print":{"date-parts":[[2020,2]]}},"alternative-id":["10.1136\/bcr-2019-233706"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-233706","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}